Rilzabrutinib (Wayrilz; Sanofi), a BTK inhibitor, targets immune-mediated platelet destruction in immune thrombocytopenia (ITP) and has demonstrated a favorable safety profile.

Approval based on the LUNA 3 phase 3 study that demonstrated rapid and durable platelet response and improvements in other ITP symptoms ITP is a rare disease of complex immune dysregulation leading to ...

Higher International Working Group–defined response rates and end-of-treatment platelet counts were achieved without increases in adverse events. Neonatal fragment crystallizable receptor (FcRn) ...

Coupang’s daily active user (DAU) count has fallen to the 14 million range following the e-commerce giant's disclosure of a massive data breach late last month, industry data showed on Monday. Seoul: ...

Your device does not support the audio. WOOD RIVER - Allison Schardan knew something was wrong with her 3-year-old son when the normal bumps and bruises of childhood started to intensify. Don't miss ...

Rifle shooting demands more than just a steady hand and a well-sighted scope—it requires the right ammunition to match your firearm, purpose, and performance expectations. Whether you’re heading to ...